Loading…
Dividends declared (per SOCE filings): FY2022 1,134 · FY2023 0 · FY2024 0 — 3-yr total 1,134
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides comprehensive hospital services with multiple affiliated subsidiary clinics and healthcare facilities. Founded in 2001 in Kutaisi; operates as a multispecialty hospital with subsidiary clinics and hotels.
Group parent — controls 1 company · ownership
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 85.1% | 88.5% | 77.0% | 76.6% | 75.1% | 68.0% | 74.8% |
| EBITDA Margin | 40.2% | 28.3% | 12.3% | 31.7% | 7.3% | -46.5% | -51.2% |
| EBITDAR | 2,806 | 2,403 | 1,551 | 6,919 | 974 | -2,848 | -3,273 |
| EBITDAR Margin | 40.2% | 28.5% | 13.0% | 31.7% | 7.3% | -46.5% | -51.2% |
| EBIT Margin | 27.0% | 15.0% | -1.4% | 25.0% | -2.9% | -71.4% | -72.7% |
| Net Profit Margin | 23.0% | 25.0% | 8.7% | 31.7% | -4.8% | -87.4% | -106.4% |
| Operating Expense % of Sales | 44.9% | 60.2% | 64.7% | 44.9% | 67.8% | 114.4% | 126.0% |
| Returns | |||||||
| Return on Assets (ROA) | 18.5% | 20.0% | 10.5% | 33.2% | -3.0% | -27.2% | -38.7% |
| Return on Equity (ROE) | 96.5% | 95.4% | 423.4% | 106.6% | -11.2% | -1631.8% | N/A |
| ROIC [EBIT / Invested Capital] | 24.6% | 16.2% | -3.0% | 40.9% | -2.5% | -29.0% | -46.6% |
| Leverage & debt balances | |||||||
| Debt-to-Assets | 70.2% | 60.2% | 61.2% | 51.0% | 66.4% | 76.1% | 94.1% |
| Debt-to-Equity | 3.67x | 2.88x | 24.56x | 1.64x | 2.53x | 45.57x | -2.55x |
| Debt-to-EBITDA | 2.18x | 2.66x | 4.11x | 1.53x | 14.73x | N/A | N/A |
| Equity-to-Assets | 19.1% | 20.9% | 2.5% | 31.2% | 26.3% | 1.7% | -36.9% |
| Net Debt | 6,008 | 5,604 | 5,219 | 6,878 | 9,623 | 14,752 | 16,443 |
| Cash & Equivalents | 101 | 754 | 781 | 3,717 | 4,730 | 200 | 73 |
| Total Debt | 6,109 | 6,358 | 6,001 | 10,596 | 14,353 | 14,952 | 16,515 |
| Liquidity & working capital | |||||||
| Current Ratio | 3.20x | 1.76x | 1.14x | 3.04x | 6.48x | 1.36x | 0.78x |
| Quick Ratio | 3.20x | 1.72x | 1.12x | 2.99x | 6.34x | 1.32x | 0.77x |
| Cash Ratio | 0.11x | 0.38x | 0.22x | 1.00x | 3.01x | 0.05x | 0.01x |
| Total Current Assets | 2,989 | 3,512 | 4,072 | 11,269 | 10,185 | 5,925 | 5,850 |
| Total Current Liabilities | 933 | 1,990 | 3,564 | 3,705 | 1,573 | 4,368 | 7,514 |
| Inventory | N/A | 94 | 80 | 180 | 212 | 147 | 64 |
| Trade Receivables | 2,674 | 2,663 | 2,859 | 6,906 | 3,015 | 1,817 | 2,087 |
| Trade Payables | 723 | 706 | 1,274 | 1,209 | 299 | 1,356 | 1,399 |
| Net Working Capital | 2,056 | 1,522 | 508 | 7,564 | 8,613 | 1,557 | -1,664 |
| Net Working Capital % of Revenue | 29.5% | 18.0% | 4.3% | 34.7% | 64.4% | 25.4% | -26.0% |
| Trade Working Capital | 1,952 | 2,052 | 1,665 | 5,877 | 2,928 | 608 | 752 |
| Trade Working Capital % of Revenue | 28.0% | 24.3% | 14.0% | 26.9% | 21.9% | 9.9% | 11.8% |
| Change in Trade Working Capital | N/A | 101 | -388 | 4,212 | -2,949 | -2,320 | 145 |
| Turnover & efficiency | |||||||
| Inventory Turnover | N/A | 10.28x | 34.48x | 28.31x | 15.73x | 13.35x | 25.04x |
| Days Inventory Outstanding (DIO) | N/A | 35.5 | 10.6 | 12.9 | 23.2 | 27.3 | 14.6 |
| Receivables Turnover | 2.61x | 3.17x | 4.16x | 3.16x | 4.44x | 3.37x | 3.06x |
| Days Sales Outstanding (DSO) | 139.9 | 115.2 | 87.7 | 115.6 | 82.3 | 108.2 | 119.2 |
| Payables Turnover | 1.44x | 1.38x | 2.15x | 4.21x | 11.14x | 1.45x | 1.15x |
| Days Payable Outstanding (DPO) | 253.8 | 265.3 | 169.6 | 86.6 | 32.8 | 252.1 | 316.9 |
| Cash Conversion Cycle | -113.9 days | -114.6 days | -71.4 days | 41.8 days | 72.7 days | -116.6 days | -183.1 days |
| Asset Turnover | 0.80x | 0.80x | 1.21x | 1.05x | 0.62x | 0.31x | 0.36x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | N/A | N/A | 27 | 2,936 | 1,013 | -4,530 | -128 |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | 27 | 2,936 | 1,013 | -4,530 | -128 |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | 1.9% | 42.4% | 103.9% | N/A | N/A |
| Dividends Declared | N/A | N/A | 0 | 1,134 | 1,134 | 0 | 0 |
| Dividend Payout Ratio | N/A | N/A | 0.0% | 16.4% | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →